NEUBERGER BERMAN GROUP LLC

Position in GMAB — Genmab A/S

CIK 1465109 NEW YORK, NY

Position in GMAB

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,447,799

-$305,367 QoQ

Shares Held

53,962

-5.2% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 86.44020681603381.ToString("F0")% Shared 0.ToString("F0")% None 13.559793183966198.ToString("F0")%

Healthcare · as of Mar 31, 2026

NEUBERGER BERMAN GROUP LLC holds $1,136,881,142 across 81 Biotechnology names. GMAB ranks #39 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,129	$330,016,949
2	VRTX	Vertex Pharmaceuticals Inc / Ma	551,522	$246,276,633
3	TECH	BIO-TECHNE Corp	3,340,837	$174,592,141
4	CAI	Caris Life Sciences, Inc.	3,590,586	$64,199,677
5	INSM	INSMED Inc	270,700	$44,264,863
6	IONS	Ionis Pharmaceuticals Inc	443,272	$33,285,294
7	ALNY	Alnylam Pharmaceuticals, Inc.	93,496	$30,935,021
8	TERN	Terns Pharmaceuticals, Inc.	480,740	$25,344,612

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,447,799	53,962	-5.2%	Shares	Defined	2026-05-14
2025-12-31	$1,753,166	56,921	+23.0%	Shares	Defined	2026-02-13
2025-09-30	$1,419,683	46,289	-1.7%	Shares	Defined	2025-11-12
2025-06-30	$972,941	47,093	+6.3%	Shares	Defined	2025-08-25
2025-03-31	$867,197	44,290	+31.5%	Shares	Defined	2025-05-13
2024-12-31	$702,776	33,674	-23.5%	Shares	Defined	2025-02-13
2024-09-30	$1,073,280	44,023	-8.5%	Shares	Defined	2024-11-14
2024-06-30	$1,209,255	48,120	-4.2%	Shares	Defined	2024-11-14
2024-03-31	$1,502,019	50,218	+28.5%	Shares	Defined	2024-11-14
2023-12-31	$1,244,784	39,095	-11.5%	Shares	Defined	2024-11-14
2023-09-30	$1,557,593	44,162	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.